Market Cap

Ovoca Bio plc Market Capitalization:

£9,379

GBP as of July 1, 2025

US$12,893

business Ovoca Bio plc Company Profile

No stock data available

Market Capitalization History of Ovoca Bio plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Ovoca Bio plc market cap

Date Market Cap YoY Change
Jan. 1, 2025 £1.3 M 72.22%
Jan. 1, 2024 £734,073 -85.00%
Jan. 1, 2023 £4.9 M -45.45%
Jan. 1, 2022 £9.0 M 4.76%
Jan. 1, 2021 £8.6 M -0.94%
Jan. 1, 2020 £8.6 M 39.47%
Jan. 1, 2019 £6.2 M -27.62%
Jan. 1, 2018 £8.6 M 10.53%
Jan. 1, 2017 £7.7 M 111.11%
Jan. 1, 2016 £3.7 M -38.98%
Jan. 1, 2015 £6.0 M -14.49%
Jan. 1, 2014 £7.0 M -41.53%
Jan. 1, 2013 £12.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Ovoca Bio plc Categories

Ireland languages Healthcare languages Biotechnology
Ireland Healthcare Ireland Biotechnology

Stocks & Indices

Ovoca Bio plc has the following listings and related stock indices.


Stock: LSE: OVB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.